Number of patients who received the service with the main diagnosis C16 (gastric cancer) or the main diagnosis Z51 and the co-diagnosis C16, and the value of benefits: Difference between revisions
From Beacon
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
Go back to [[Poland]] page | |||
''Type of Information''': Year; Sex; Age group; Type of benefit; Refund value and number of patients. | |||
'''Source of Information''': Data prepared on the basis of data from the National Health Fund headquarters as of 2021-11-10. | '''Source of Information''': Data prepared on the basis of data from the National Health Fund headquarters as of 2021-11-10. | ||
Revision as of 19:00, 16 June 2023
Go back to Poland page
Type of Information': Year; Sex; Age group; Type of benefit; Refund value and number of patients.
Source of Information: Data prepared on the basis of data from the National Health Fund headquarters as of 2021-11-10.
Data level: National.
Number of Records: Unknown.
Date Range: 2013-2020.
Cancer Areas of Interest: Malignant neoplasm of stomach (C16); Encounter for other aftercare and medical care (Z51).
Open data access: Publicly available [1].
Information/Contact for data request: Contact information can be found [2].
